Access to anti,anti-4-Aminopiperidine-3,5-diols
44.0, 55.5, 58.5, 59.7, 71.1, 79.5, 82.4, 113.9, 119.6, 131.6, 156.1,
156.3, 165.8; IR (CHCl3, cm-1) ν 3462, 1747, 1709; MS (ES) m/z
480 (M+•, 5), 407 (M - 73, 4), 367 (42), 323 (11), 307 (51), 234
(41), 201 (100), 149 (77), 73 (84), 57 (80). Anal. Calcd for
C24H40N2O6Si: C, 59.97; H, 8.39; N, 5.83. Found: C, 60.13; H,
8.62; N, 5.74.
General Procedure for the Preparation of 3-Amino-5-hy-
droxypentanenitriles 6. Lithium borohydride (2.25 mmol) was
added in portions to a solution of the appropriate O-silylated
cyanohydrin 3 (0.75 mmol) in anhydrous diethyl ether (18.6 mL)
at 0 °C under argon. The reaction mixture was allowed to warm to
room temperature and stirred until disappearance of starting material
(TLC). Then, a saturated aqueous solution of NaHCO3 (20 mL)
was added, and the resulting mixture was extracted with ethyl
acetate (5 × 55 mL). The organic layer was dried (MgSO4), and
the solvent was removed under reduced pressure. Flash chroma-
tography on silica gel of the residue, eluting with hexanes/ethyl
acetate mixtures, gave compounds 6.
(+)-(2S,3R,4R)-2-{[tert-Butyl(dimethyl)silyl]oxy}-5-hydroxy-
4-methoxy-3-[(4-methoxyphenyl)amino]pentanenitrile, (+)-6a.
From 280 mg (0.74 mmol) of cyanohydrin syn-(+)-3a, compound
(+)-6a (232 mg, 82%) was obtained as a pure colorless oil after
purification by flash chromatography (hexanes/ethyl acetate 3:1):
[R]D ) +13.3 (c 0.9, CHCl3); 1H NMR (200 MHz, CDCl3) δ 0.119
(s, 3H), 0.203 (s, 3H), 0.914 (s, 9H), 3.575 (s, 3H), 3.756 (s, 3H),
3.842-3.702 (m, 4H), 4.623 (d, 1H, J ) 5.6 Hz), 6.644 (AA′BB′,
2H), 6.791 (AA′BB′, 2H); 13C NMR (50 MHz, CDCl3) δ -5.4,
-5.2, 18.0, 25.5, 55.7, 58.3, 59.0, 62.0, 62.0, 77.6, 115.2, 115.3,
118.5, 139.5, 153.2; IR (CHCl3, cm-1) ν 3393; MS (ES) m/z 380
(M+•, 6), 305 (M+• - 75, 2), 210 (M+• - 170, 100), 178 (24), 160
(53). Anal. Calcd for C19H32N2O4Si: C, 59.97; H, 8.48; N, 7.36.
Found: C, 59.79; H, 8.62; N, 7.02.
General Procedure for Preparation of Carbamates 10 and
Amides 15. To a solution of diacetoxy iodobenzene (DIB) (1.70
mmol) in a mixture of methanol (4.7 mL) and acetic acid (0.10
mL) was slowly added a solution of the corresponding 3-amino-
5-hydroxypentanenitrile 6 (0.42 mmol) in methanol (1.2 mL) over
20 min. Upon complete addition, the reaction was stirred at rt for
30 min. Then, a 10% aq HCl solution (4.8 mL, wt %) was added.
The mixture was stirred for 30 min, at which time a 10% aq
Na2S2O3 solution (4.8 mL, wt %) was added, and stirring was
allowed to continue for an additional 30 min. After that, sodium
carbonate was added until the solution was made basic (for
carbamates 10) or neutral (for amides 15), and a solution of di-
tert-butyl dicarbonate or acetic anhydride (1.70 mmol) in DCM (2
mL) was added as required. The mixture was stirred overnight at
rt. Afterward, methanol was removed under reduced pressure, and
the resulting mixture was extracted with DCM (4 × 40 mL). The
organic layer was dried (MgSO4) and concentrated under reduced
pressure. Flash chromatography on silica gel of the residue eluting
with hexanes/ethyl acetate mixtures afforded analytically pure
carbamate 10 or amide 15.
(-)-N-{(1R,2R)-2-(Benzyloxy)-1-[(S)-{[tert-butyl(dimethyl)-
silyl]oxy}(cyano)methyl]-3-hydroxypropyl}acetamide, (-)-15b.
From 196 mg (0.43 mmol) of (+)-6b and, after flash chromatog-
raphy (hexanes/ethyl acetate 1:1), two fractions were obtained. From
the more polar one, compound (-)-15b (93 mg, 55%) was obtained
as a pure pale brown oil: [R]D ) -27.3 (c 0.4, CHCl3); 1H NMR
(300 MHz, CDCl3) δ 0.184 (s, 3H), 0.240 (s, 3H), 0.937 (s, 9H),
2.024 (s, 3H), 3.492 (m, 1H), 3.681 (m, 1H), 4.071 (ddd, 1H, J )
7.3, 5.5, 1.6 Hz), 4.314 (ddd, 1H, J ) 8.5, 6.6, 1.8 Hz), 4.628 (d,
1H, J ) 11.0 Hz), 4.686 (d, 1H, J ) 6.3 Hz), 4.782 (d, 1H, J )
10.8 Hz), 6.116 (d, 1H, J ) 8.8 Hz), 7.426-7.309 (m, 5H); 13C
NMR (50 MHz, CDCl3) δ -5.4, -5.3, 18.0, 23.1, 25.5, 52.2, 61.2,
61.4, 73.9, 75.0, 118.5, 128.3, 128.6, 128.6, 137.3, 171.2; IR
(CHCl3, cm-1) ν 3427, 1661; MS (ES) m/z 335 (M+• - 57, 29),
222 (M+• - 170, 16), 91 (100). Anal. Calcd for C20H32N2O4Si: C,
61.19; H, 8.22; N, 7.14. Found: C, 61.34; H, 8.02; N, 6.99. From
the less polar fraction, (+)-(2S)-[(4R,5R)-5-(benzyloxy)-1,3-ox-
azinan-4-yl]{[tert-butyl(dimethyl)silyl]oxy}acetonitrile, (+)-16b
(24 mg, 15%) was isolated as a pure pale brown oil: [R]D ) +5.4
(c 0.5, CHCl3); 1H NMR (300 MHz, CDCl3) δ 0.154 (s, 3H), 0.211
(s, 3H), 0.924 (s, 9H), 3.133 (dd, 1H, J ) 7.4, 2.1 Hz), 3.598 (br
s, 1H), 3.598 (d, 1H, J ) 11.7 Hz), 4.241 (d, 1H, J ) 11.7 Hz),
4.265 (d, 1H, J ) 10.4 Hz), 4.561 (d, 1H, J ) 7.4 Hz), 4.626 (d,
1H, J ) 11.4 Hz), 4.662 (d, 1H, J ) 10.2 Hz), 4.720 (1H, d, J )
11.5 Hz), 7.445-7.307 (m, 5H); 13C NMR (75 MHz, CDCl3) δ
-5.2, -5.2, 18.1, 25.5, 60.6, 63.0, 67.4, 70.0, 71.5, 79.3, 118.3,
127.9, 128.2, 128.4, 137.5; IR (CHCl3, cm-1) ν 3310; MS (ES)
m/z 361 (M+• - 1, 1), 305(M+• - 57, 20), 192 (M+• - 170, 69),
91 (100). Anal. Calcd for C19H30N2O3Si: C, 62.95; H, 8.34; N,
7.73. Found: C, 63.03; H, 8.37; N, 7.54.
General Procedure for Preparation of Mesylates 11 and 17.
Triethylamine (1.12 mmol), DMAP (cat.), and methanesulfonyl
chloride (0.56 mmol) were sequentially added dropwise via syringe
to a solution of the corresponding alcohol, 10 or 15 (0.28 mmol),
in anhydrous DCM (4.4 mL) at rt under argon atmosphere. The
resulting mixture was stirred until disappearance of starting material
(TLC). The crude mixture was diluted with DCM (60 mL) and
washed successively with an aq saturated solution of NH4Cl (1 ×
15 mL) and brine (1 × 15 mL). The organic layer was dried
(MgSO4), filtered, and concentrated under reduced pressure. Chro-
matography of the residue eluting with hexanes/ethyl acetate
mixtures gave analytically pure mesylates 11 or 17, respectively.
(-)-(2R,3R,4S)-3-[(tert-Butoxycarbonyl)amino]-4-{[tert-butyl-
(dimethyl)silyl]oxy}-4-cyano-2-methoxybutyl Methanesulfonate,
(-)-11a. From 75 mg (0.20 mmol) of (-)-10a, compound (-)-
11a (76 mg, 84%) was obtained as a pure pale brown oil after
purification by flash chromatography (hexanes/ethyl acetate 4:1):
[R]D ) -3.7 (c 0.5, CHCl3); 1H NMR (300 MHz, CDCl3) δ 0.188
(s, 3H), 0.242 (s, 3H), 0.934 (s, 9H), 1.449 (s, 9H), 3.047 (s, 3H),
3.569 (s, 3H), 3.910 (1H, dd, J ) 8.3, 6.1 Hz), 4.018 (t, 1H, J )
6.0 Hz), 4.146 (dd, 1H, J ) 10.4, 6.2 Hz), 4.277 (dd, 1H, J )
10.4, 5.9 Hz), 4.618 (d, 1H, J ) 5.9 Hz), 5.133 (d, 1H, J ) 9.5
Hz); 13C NMR (75 MHz, CDCl3) δ -5.4, -5.3, 17.9, 25.4, 28.2,
37.5, 53.2, 59.7, 61.6, 67.2, 74.5, 80.71, 118.2, 155.2; IR (CHCl3,
cm-1) ν 1712; MS (ES) m/z 379 (M+• - 73, 32), 339 (M+• - 57
- 56, 100), 295 (M+• - 57 - 56 - 44, 14), 282 (M+• - 170, 22),
243 (M+• - 153 - 56, 50), 226 (M+• - 170 - 56, 22), 182 (M+•
- 170 - 56 - 44, 81), 153 (42), 86 (M+• - 170 - 56 - 44 - 96,
62), 75 (19), 73 (29), 57 (57). Anal. Calcd for C18H36N2O7SSi: C,
47.76; H, 8.02; N, 6.19. Found: C, 47.87; H, 8.19; N, 5.99.
General Procedure for Preparation of Piperidines 12. Starting
from methane sulfonates 11, piperidines 12 were obtained adopting
the same protocol indicated above for the synthesis of amino
â-lactams 4.
(-)-tert-Butyl (1R,2R)-1-[(S)-{[tert-Butyl(dimethyl)silyl]oxy}-
(cyano)methyl]-3-hydroxy-2-methoxypropylcarbamate, (-)-10a.
From 134 mg (0.35 mmol) of (+)-6a, compound (-)-10a (77 mg,
58%) was obtained after purification by flash chromatography
(hexanes/ethyl acetate 3:1) as a pure pale yellow oil: [R]D ) -6.8
(c 0.4, CHCl3); 1H NMR (300 MHz, CDCl3) δ 0.185 (s, 3H), 0.242
(s, 3H), 0.935 (s, 9H), 1.452 (s, 9H), 2.402 (t, 1H, J ) 6.3 Hz),
3.525 (s, 3H), 3.530 (m, 1H), 3.751 (m, 2H), 3.982 (dd, 1H, J )
8.2, 6.7 Hz), 4.624 (d, 1H, J ) 6.3 Hz), 5.053 (d, 1H, J ) 9.3 Hz);
13C NMR (50 MHz, CDCl3) δ -5.4, -5.3, 18.0, 25.5, 28.2, 53.5,
59.2, 60.9, 62.0, 77.4, 80.6, 118.4, 156.2; IR (CHCl3, cm-1) ν 3447,
1703; MS (ES) m/z 347 (M+• - 27, 8), 301 (M+• - 73, 30), 261
(M+• - 57 - 56, 100), 217 (M+• - 57 - 56 - 44, 42), 204 (M+•
- 170, 37), 148 (M+• - 170 - 56, 77), 104 (M+• - 170 - 56 -
44, 81), 75 (42), 73 (37), 57 (86). Anal. Calcd for C17H34N2O5Si:
C, 54.51; H, 9.15; N, 7.48. Found: C, 54.61; H, 9.33; N, 7.35.
(-)-tert-Butyl (3R,4R,5S)-3-{[tert-Butyl(dimethyl)silyl]oxy}-
5-methoxypiperidin-4-yl-carbamate, (-)-12a. From 60 mg (0.13
mmol) of mesylate (-)-11a, and after purification by flash
chromatography on silica gel, eluting first with ethyl acetate and
finally with methanol, compound (-)-12a (28 mg, 59%) was
J. Org. Chem, Vol. 72, No. 21, 2007 7989